vibegron
CHEBI:CHEBI_142418
Definition
A pyrrolopyrimidine obtained by formal condensation of the carboxy group of (6S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylic acid with the amino group of (R)-[(2R,5S)-5-(4-aminobenzyl)pyrrolidin-2-yl](phenyl)methanol. It is a beta3-adrenergic receptor agonist currently in clinical development for the treatment of patients with overactive bladder.
Chemical Information
- Molecular Formula
- C26H28N4O3
- Molecular Mass
- 444.527
- Charge
- 0
- SMILES
- C(NC1=CC=C(C=C1)C[C@@H]2CC[C@@H](N2)[C@@H](C3=CC=CC=C3)O)([C@H]4N5C(C=CN=C5CC4)=O)=O
- InChI
- InChI=1S/C26H28N4O3/c31-24-14-15-27-23-13-12-22(30(23)24)26(33)29-19-8-6-17(7-9-19)16-20-10-11-21(28-20)25(32)18-4-2-1-3-5-18/h1-9,14-15,20-22,25,28,32H,10-13,16H2,(H,29,33)/t20-,21+,22-,25+/m0/s1
- InChIKey
- DJXRIQMCROIRCZ-XOEOCAAJSA-N
Alternative Names
- (6S)-N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide
- Beova
- MK-4618
- vibegron
- vibegronum
Drug Classification
-
pyrrolopyrimidineView Class →
CHEBI:38670
-
processed material
-
secondary carboxamideView Class →
CHEBI:140325
-
benzenesView Class →
CHEBI:22712
-
secondary alcoholView Class →
CHEBI:35681
-
secondary amineView Class →
CHEBI:32863
-
pyrrolidinesView Class →
CHEBI:38260
-
t111533
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 2472254
- oboInOwl#hasDbXref
- Reaxys:19541234
- core#notation
- CHEBI:142418
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 2472254
- oboInOwl#hasDbXref
- Reaxys:19541234
- oboInOwl#id
- CHEBI:142418
- core#notation
- CHEBI:142418
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_35522
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_0111671
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect5276
- owl#annotatedSource
- t112519
- owl#someValuesFrom
- t3866016